PHARMATREN H 100

Description

Chemical name: Cyclohexylmethyl (17β)-3-oxoestra-4,9,11-trien-17-yl carbonate Formula: C26H34O4 Anabolic activity index: 500% Androgenic activity index: 500% PHARMATREN H100 – PHARMACOM LABS 1 VIAL X 10 ML X 100 MG/ML PHARMATREN H100, featuring Trenbolone hexahydrobenzylcarbonate, represents the pinnacle of efficiency among anabolic steroids. Recognized for its unparalleled ability to enhance muscle hardness, definition, and raw strength, this longer-acting form extends the benefits of Trenbolone compared to its counterpart, PHARMATREN A100. Trenbolone, introduced in 1967, stands as an exceptionally potent 19-nor modification of testosterone, boasting fivefold strength in both anabolic and androgenic activities. Benefits: Muscle Hardness and Definition: Highly esteemed for augmenting muscle hardness, definition, and raw strength. Extended Release: With a half-life of approximately 14 days, tailored for prolonged cycles. Nutrient Efficiency: Elevates the nutritional efficiency of proteins, fats, and carbohydrates, enhancing assimilation. Protein Synthesis: Accelerates protein synthesis, pivotal for rapid muscle development. Positive Nitrogen Balance: Maintains a positive nitrogen balance, supporting ongoing protein construction. IGF-1 Surge: Up to a 200% increase in the anabolic hormone IGF-1 within muscle tissue, fostering muscle growth. Muscle Satellite Cells: Renders muscle satellite cells more sensitive to growth factors, potentially increasing DNA per muscle cell. Red Blood Cell Production: Remarkably boosts red blood cell production, enhancing oxygen transport critical for muscular endurance. Glycogen Replenishment: Promotes significant glycogen replenishment, aiding in post-exertion recovery. Anti-Glucocorticoid Effects: Substantially reduces the production of muscle-degrading glucocorticoid hormones, notably cortisol. Direct Fat Burning Stimulation: Binds directly to androgen receptors, surpassing testosterone in directly stimulating fat burning. Side Effects: Progestogenic Activity: As a 19-nor modification, Trenbolone exhibits progestogenic activity akin to nandrolone. Prolactin Inhibitors: Use of prolactin inhibitors (cabergoline) recommended if progestogenic effects arise. Dosage Instructions: Cycle Duration: Ideal for extended cycles due to its prolonged release. Dosage Range: Typical dosage ranges from 150-300 mg per week. Initial Dose: Commence with a lower dose to monitor body response and minimize potential side effects. Monitoring: Regularly assess body response for adjustments in dosage if needed. Caution and PCT Recommendations: Tamoxifen Warning: Tamoxifen during Trenbolone cycles and PCT may intensify progestogenic activity and is not advised. PCT Recommendations: Clomid or toremifene are recommended for post-cycle therapy following all 19-nor testosterone modifications.